PNC Financial Services Group
HBIO icon

PNC Financial Services Group’s Harvard Bioscience HBIO Stock Holding History

PNC Financial Services Group’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68 Hold
14
– – ﹤0.01% 5111
2025
Q4 		$96 Sell
14
-740
-98% -$4.39K ﹤0.01% 5055
2025
Q3 		$3.31K Hold
754
– – ﹤0.01% 4356
2025
Q2 		$3.35K Sell
754
-38
-5% -$159 ﹤0.01% 4257
2025
Q1 		$4.48K Buy
792
+274
+53% +$3.51K ﹤0.01% 4103
2024
Q4 		$10.9K Buy
518
+513
+10,260% +$11.8K ﹤0.01% 3773
2024
Q3 		$145 Hold
5
– – ﹤0.01% 4702
2024
Q2 		$154 Buy
+5
New +$175 ﹤0.01% 4696
2024
Q1 		– Sell
-2
Closed -$118 – 4741
2023
Q4 		$118 Buy
+2
New +$90 ﹤0.01% 4511
2018
Q3 		– Sell
-15
Closed -$1K – 4169
2018
Q2 		$1K Sell
15
-339
-96% -$17.4K ﹤0.01% 4057
2018
Q1 		$18K Hold
354
– – ﹤0.01% 3484
2017
Q4 		$12K Hold
354
– – ﹤0.01% 3622
2017
Q3 		$13K Buy
+354
New +$10.5K ﹤0.01% 3579
2014
Q4 		– Sell
-40
Closed -$2K – 4190
2014
Q3 		$2K Buy
+40
New +$1.84K ﹤0.01% 3661

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $100M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PNC Financial Services Group's HBIO Position: Q1 2026 in Review

PNC Financial Services Group held its Harvard Bioscience (HBIO) position steady in Q1 2026 at 14 shares worth $68. The position accounts for ﹤0.01% of the portfolio, ranked #5111.

PNC Financial Services Group first reported a position in HBIO in Q3 2014 and has held it in 14 quarters since. The position peaked at $18K in Q1 2018. 36 funds tracked by Wall St. Rank hold HBIO as of Q1 2026.

  • PNC Financial Services Group held 14 shares of Harvard Bioscience worth $68 as of Q1 2026.
  • PNC Financial Services Group left its Harvard Bioscience share count unchanged in Q1 2026.
  • Harvard Bioscience made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #5111 holding.
  • PNC Financial Services Group first reported a position in Harvard Bioscience in Q3 2014 and has held it in 14 quarters since.
  • PNC Financial Services Group's Harvard Bioscience position peaked at $18K in Q1 2018.
  • 36 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.